← Leaderboards
Qigui Yu
University Of Hawaii At Manoa
$5,436,030
Attributed
$5,985,157
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $925.3K · FY2007–23$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,985,157 · 7
By mechanism
R01$1,930,382 · 1
R33$1,159,308 · 1
UH3$962,940 · 1
R56$823,691 · 1
R21$790,843 · 2
UH2$317,993 · 1
Top collaborators
- Yunlong Liu1 shared
- Huanbin Xu1 shared
Most similar at University Of Hawaii At Manoa
Same institution · by research overlap
- Michael Jay Corley$10,965,948
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInnovationProvirusesIn VivoT-LymphocyteImmunityHiv-1In VitroPathogenesisMemoryAntibodiesInfectionImmuneCd4 Positive T LymphocytesCell TypeCell LineAntiretroviral TherapyScientistInhibitor/AntagonistVirus IntegrationRestChronicViralVirus Replication
Grant awards (18)
Immune checkpoints in the CNS and HIV-associated neurocognitive disorder$823,691
R56 · FY2023 · NS · contact PI
Alcohol's impact on immunological and virological profiles in HIV patients$301,782
UH3 · FY2021 · AA · contact PI
Alcohol's impact on immunological and virological profiles in HIV patients$348,035
UH3 · FY2020 · AA · contact PI
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1$385,841
R01 · FY2019 · AI · contact PI
Alcohol's impact on immunological and virological profiles in HIV patients$313,123
UH3 · FY2019 · AA · contact PI
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1$385,962
R01 · FY2018 · AI · contact PI
Alcohol's impact on immunological and virological profiles in HIV patients$165,188
UH2 · FY2018 · AA · contact PI
Specific killing of latently HIV-1-infected cells after provirus reactivation$386,436
R33 · FY2017 · AI · contact PI
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1$386,080
R01 · FY2017 · AI · contact PI
Alcohol's impact on immunological and virological profiles in HIV patients$152,805
UH2 · FY2017 · AA · contact PI
Specific killing of latently HIV-1-infected cells after provirus reactivation$386,436
R33 · FY2016 · AI · contact PI
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1$386,194
R01 · FY2016 · AI · contact PI
Specific killing of latently HIV-1-infected cells after provirus reactivation$386,436
R33 · FY2015 · AI · contact PI
Targeting latently infected Tfh cells to achieving a functional cure of HIV-1$386,305
R01 · FY2015 · AI · contact PI
Specific killing of latently HIV-1-infected cells after provirus reactivation$234,000
R21 · FY2014 · AI · contact PI
Specific killing of latently HIV-1-infected cells after provirus reactivation$195,000
R21 · FY2013 · AI · contact PI
Development of Molecular Adjuvants for Therapeutic HIV-1 Vaccines$188,843
R21 · FY2008 · AI · contact PI
Development of Molecular Adjuvants for Therapeutic HIV-1 Vaccines$173,000
R21 · FY2007 · AI · contact PI